The incidence of in situ carcinoma of the breast among women in the USA has increased about 4-fold since 1973, in contrast to only a slight increase in invasive breast cancer incidence (Hankey et al., 1993) . As a result, in situ tumours accounted for about 12% of diagnosed breast cancers in 1990, compared with less than 5% in the period 1973-80. The increased use of mammographic screening during these years explained most of the increase among older women (Lantz et al., 1991; Liff et al., 1991; Feuer and Wun, 1992) . It is less likely that the 3-fold increase in incidence of in situ tumours that occurred among women aged less than 50 is caused by screening, owing to the low prevalence of screening among women in this age group (White et al., 1990; Lantz et al., 1991) .
The incidence of in situ carcinoma of the breast among women in the USA has increased about 4-fold since 1973, in contrast to only a slight increase in invasive breast cancer incidence (Hankey et al., 1993) . As a result, in situ tumours accounted for about 12% of diagnosed breast cancers in 1990, compared with less than 5% in the period 1973-80. The increased use of mammographic screening during these years explained most of the increase among older women (Lantz et al., 1991; Liff et al., 1991; Feuer and Wun, 1992) . It is less likely that the 3-fold increase in incidence of in situ tumours that occurred among women aged less than 50 is caused by screening, owing to the low prevalence of screening among women in this age group (White et al., 1990; Lantz et al., 1991) .
There are two main types of in situ breast carcinoma, the ductal and lobular forms, and their relationship with invasive breast cancer is not clearly understood. Ductal carcinoma in situ (DCIS) can be detected by mammography and is thought to represent a transitional stage in the development of an invasive tumour, with over 25-50% of tumours progressing to invasion, usually in the same breast (Ponten et al., 1990; Bodian, 1993) . In contrast, lobular carcinoma in situ is not clinically detectable by mammography and is usually an incidental finding during a biopsy. LCIS is probably a marker of high risk of subsequent invasive cancer in either breast, rather than a transitional stage in invasive malignancy (Ponten et al., 1990 ) and the risk of developing invasive breast cancer following biopsy-treated LCIS is approximately 8% in both ipsilateral and contralateral breasts (Bodian, 1993) . Evidence of the association between in situ and invasive disease (i.e. local or regional/distant tumours) was strengthened recently by research showing that the tumoursuppressor gene on chromosome 11 is mutated or missing in both invasive and in situ breast cancer (Holzman, 1995) . The rapid increase in incidence of in situ tumours has prompted recent epidemiological studies to include in situ tumours as well as invasive tumours in analyses, but few studies have examined differences in risk factors by stage of disease. A follow-up study carried out within a nationwide screening programme [the Breast Cancer Demonstration Detection Project (BCDDP), Brinton et al., 1983 ] found a number of shared risk factors for in situ and invasive tumours, including a family history of breast cancer, previous breast biopsy and late age at first livebirth. However, this study was limited by lack of information on complete screening history. Results from another study (Dubin et al., 1984) showed no evidence that in situ tumours were associated with family history of breast cancer or a previous breast biopsy, although there was a significant association with a breast lump or cyst, and for African-American women compared with white women.
The present case-control study is the largest study of women aged under 45 to compare risk factors for in situ, local and regional/distant breast cancer. In addition, risk factors for histological types of in situ tumours have been examined. The role of screening bias is especially important in studies of non-invasive tumours, as screening procedures such as frequent mammograms are likely to detect tumours at an early stage. In this study, detailed screening information was collected at the time of interview for cases and controls, allowing the effect of screening on stage at diagnosis to be evaluated.
Materials and methods
This population-based case-control study was conducted in three different geographic areas of the USA covered by cancer registries -Atlanta, Seattle/Puget Sound and five counties in central New Jersey. Study details have been published elsewhere (Brinton et al., 1995 Relative risks (RRs) and 95% confidence intervals (CIs) were calculated by nominal polychotomous logistic regression (Dubin and Pasternack, 1986 ) using the computer package BMDP (Dixon, 1990) . This is an extension of dichotomous logistic regression, and is applicable to case-control studies involving more than two disease categories. (Armitage and Berry, 1987) . The association between two screening methods was measured by the kappa statistic (Fleiss 1973 Table III shows the frequency of mammographic screening in the 5 year period more than a year before reference date, by selected breast cancer risk factors. Overall, 14% of women had undergone at least three mammograms in this period. Of women with a family history of breast cancer in a first-degree relative, 29% had three or more mammograms in this period, compared with 12% of women without a family history. Similarly, 37% of women with a breast biopsy had had three or more mammograms compared with 12% of women without a breast biopsy. The differences between these proportions were statistically significant (P < 0.001). White women were more likely to have undergone frequent screening than African-American women (15% vs 9%; P < 0.001), as were women with at least some college education compared with those with no college education (15% vs 12%; P=0.03). Table IV shows relative risks for each stage of cancer, associated with a family history of breast cancer, a previous breast biopsy and race. Breast cancer in a first-degree relative was associated with more than a 2-fold risk for each stage of cancer, and there was no evidence of heterogeneity between the RRs for any two stages at diagnosis (P>0.57). The magnitude of risk tended to be slightly greater among women with only an affected mother than among women with only an affected sister, although the numbers of women with an affected sister were small and confidence intervals were wide. Women with both a mother and sister affected were at the greatest risk for each stage of disease, although again these results are based on very small numbers.
A previous breast biopsy was associated with a significant 2-fold relative risk for in situ tumours (RR= 1.99) and smaller, non-significant, increased risks for local and regional/distant tumours (RRL= 1.23, RRR/D =1.28). The test for heterogeneity showed that the magnitude of risk was significantly greater for in situ tumours than for local tumours (P=0.04), and to a lesser extent, regional/distant tumours (P= 0.08). Further analyses showed that the increased risk for in situ tumours was confined to women aged 25 or older at first biopsy (RR< 25ys = 0.64, RR25 34 yrs = 2.44, RR35 44yrs = 2.43).
There was an increased risk for African -American women compared with white women for all stages of disease. The risk was greater for in situ tumours (RR= 1.84), than for local (RR= 1.25) or regional/distant tumours (RR= 1.38), but the differences in risk by stage were not statistically significant (Pk0.12). No effect was seen for other non-white races, although results were based on small numbers. b Calculated using the chi-square test for a difference in proportions (Fleiss, 1973) .
Relative risks associated with menstrual and reproductive factors are shown in Table V . There was some evidence of an increased risk of local tumours among women with an early age at menarche, but this was not apparent for either in situ or regional/distant tumours. Nulliparous women were at a significantly increased risk of in situ (RR = 2.10) and local (RR= 1.65) tumours compared with parous women, and to a lesser extent of regional/distant tumours (RR = 1.21). A test of heterogeneity showed some evidence of a difference in relative risk associated with parity for in situ tumours compared with regional/distant tumours (P = 0.05), but no significant difference between the risks for in situ and local (P=0.36), or local and regional/distant tumours (P=0.11).
Among parous women, there was a borderline significant decreasing trend in RR with increasing parity for both in situ and local tumours. In both groups, women with four or more full-term births were at almost half the risk of women with one full term birth. In contrast, there was no clear effect of increasing parity on the risk of regional/distant tumours.
For regional/distant tumours there was a significant increasing risk with older age at first full-term birth (RR>30= 1.69; P-value for trend=0.02). There was less evidence of a rising risk with increasing age at first birth for local tumours (RR>,30= 1.37; P-value for trend=0.16), and for in situ tumours (RR>30= 1.34; P-value for trend =0.13). There was no evidence of heterogeneity Relative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, a combination variable including number of full-term births and age at first full-term birth, years of oral contraception use, body mass index and number of mammograms in the 5 years prior to 1 year before reference date. b Relative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, age at first full-term birth, years of oral contraception use, body mass index and number of mammograms in the 5 years prior to 1 year before reference date. c Among parous women only. Relative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, years of oral contraception use, body mass index, number of mammograms in the 5 years prior to 1 year before reference date, and the other reproductive variables in this (Brinton et al., 1983; Claus et al., 1993) in showing that risk factors for in situ tumours are broadly similar to those for local and regional/distant tumours. In addition, this is the only study to focus on the epidemiology of in situ tumours among young women. The BCDDP study (Brinton et al., 1983) (Reeves et al., 1995) . A possible source of residual confounding arises from differing methods used to detect the tumours. To assess this potential confounding in the present study, further analyses were carried out using case data only (Begg and Zhang, 1994) . Relative risks for models including a risk factor, screening history and other confounders were calculated for local and regional/distant tumours relative to in situ tumours. The addition of detection method in the model had little effect on the odds rations, giving no evidence of residual confounding by method of detection.
A history of breast cancer in a first-degree relative is an established risk factor, especially among younger women (Eby et al., 1994) , and in this study a greater than 2-fold risk was seen for each stage of diagnosis. The risks in the BCDDP study were slightly lower (RR= 1.5, Brinton et al., 1983) , possibly because the controls in that study had volunteered to be screened and may have had a higher prevalence of a family history of breast cancer than the general population.
Previous studies have shown a greater risk of in situ compared with invasive tumours among patients with previous breast biopsies or benign breast disease (Brinton et al., 1983; Dubin et al., 1984; Claus et al., 1993) , possibly as a result of early detection through frequent screening. In the present study, the magnitude and significance of the increased risk associated with a breast biopsy was greater for in situ tumours than for local or regional/distant tumours, even after adjusting for number of mammograms. Benign breast disease is an established risk factor for invasive breast cancer, and women with atypical hyperplasia are at a particularly high risk (Bodian, 1993; Ma and Boyd, 1992) . The greater association of biopsy with in situ tumours than with local or regional/distant tumours supports the close relationship between benign tumours, carcinoma in situ and invasive carcinoma (Bodian, 1993) . It is also possible that the lack of a clear demarcation between atypical hyperplasia and in situ tumours may result in diagnostic misclassification, leading to the observed association (Bodian, 1993; Marcus et al., 1994 ).
An increased breast cancer risk among young AfricanAmerican women compared with white women remains largely unexplained (Kelsey and Horn Ross, 1993) , and in this study the increase persisted after adjusting for possible confounders. The increased risk for in situ disease among African-Americans was also found in a case-control study of a screened population of women aged over 35, but, in contrast, no increase was seen for invasive disease (Dubin et al., 1984) .
Early age at menarche is an established risk factor for breast cancer . There was some evidence of an increased risk with earlier age at menarche for local tumours, but no association with carcinoma in situ. The BCDDP study also found no association with in situ tumours or small tumours, but there was a significant increasing trend with younger age at menarche for tumours greater than 1 cm (Brinton et al., 1983) .
Nulliparity is also an established breast cancer risk factor, though the increased risk is not so apparent among women aged less than 40 (Janerich and Hoff, 1982; Kelsey et al., 1304 Velentgas and Daling, 1994 ). The present study shows variation in the effect of parity by stage of disease. Nulliparous women were at a significantly increased risk of in situ and local tumours. Women with four or more fullterm births were at about half the risk of women with a single birth, for both in situ and local disease. This reduction in risk has not been seen previously (Dubin et al., 1984 (Velentgas and Daling, 1994) , and was significantly associated with regional/distant tumours and to a lesser extent, in situ and local tumours. The BCDDP study (Brinton et al., 1983) showed a significant increase in risk of all stages of disease with increasing age at first birth, but another study showed no relationship between in situ tumours and age at first birth (Dubin et al., 1984) . Consumption of a lifetime average of two or more alcoholic drinks per day was associated with a significantly increased risk of regional/distant tumours in this study. To our knowledge, the relationship between stage of breast cancer and alcohol consumption has not previously been examined, but other studies have found overall associations with alcohol consumption (Rosenberg et al., 1993) . The association has been seen in both cohort and case-control studies, and persists after adjustment for known confounding factors. If alcohol consumption is indeed a causal factor of breast cancer, it would be one of few readily modifiable risk factors known (the others being physical exercise in younger women and weight loss in older women; Brinton, 1994) . However, no definite biological explanation for the association is known. There are several possible mechanisms including the stimulation of prolactin secretion, decreased clearance of oestrogen by the liver (Velentgas and Daling, 1994) , or possibly an alcohol-induced increase in total oestrogen levels (Reichman et al., 1993) , and further research is needed in this area. The lack of a significant increased risk for in situ tumours found in the present study may be due to small numbers, or may indicate that alcohol affects the progression of tumours from in situ to invasive. Detailed analyses of alcohol intake in this study are currently underway.
Some studies have shown an inverse association between body mass index and breast cancer risk in premenopausal women (Hunter and Willet, 1993) , and the relationship in the present study has been analysed previously (Swanson et al., 1996) . Small tumours are more difficult to detect in obese women, but the reduced risk of in situ and local tumours associated with increased BMI is unlikely to be due to detection bias since the inverse relationship held among women whose tumours were found by mammography, a detection method unlikely to be affected by BMI (Swanson et al., 1996) .
A previously published analysis of this data (Brinton et al., 1995) has examined the RRs of different stages of breast cancer associated with use of oral contraceptives, and found that use for at least 6 months was associated with both local and regional/distant tumours, but not in situ tumours. This supports evidence from other studies (Kay and Hannaford, 1988; Romieu et al., 1989; Olsson et al., 1991) This study is one of the largest to examine risk factors by histological type of early-stage breast cancer and our results support the theory that ductal carcinoma in situ is more closely related to invasive breast cancer than the lobular form. Results from studies of risk factors by histological types of in situ breast cancer have been inconsistent (Marcus et al., 1994) . The association between family history and DCIS has been suggested previously (Erdreich et al., 1980) but the present study is the first to show a significantly increased risk. Several previous studies (Rosen et al., 1982; Claus et al., 1993) have suggested that LCIS is related to family history. The 4-fold risk of LCIS following a previous breast biopsy is not unexpected, as LCIS is usually detected as a result of a biopsy given for some other reason (Bodian, 1993) .
To conclude, this study provides epidemiological support for the theory that in situ, local and regional/distant breast cancer are closely related. Increased risks of similar magnitude for all stages of disease were associated with a family history of breast cancer. For some risk factors, including a previous breast biopsy, parity, African-American race and body mass index, the magnitude of association was greater for in situ disease than for local or regional/ distant disease and this persisted after adjustment for number of mammograms, indicating that it was not due to screening bias. This tends to suggest that in situ tumours are likely to be on the causal pathway of invasive tumours. The significant association between alcohol consumption and invasive tumours, but not in situ tumours, indicates that alcohol may be involved in late-stage events. Analyses by histological type of in situ tumours suggested that both ductal and lobular carcinoma in situ were associated with most established breast cancer risk factors, and the magnitude of association tended to be greater for the ductal form.
